I Mab Top Management

IMABDelisted Stock  USD 4.64  0.06  1.28%   
I Mab employs about 32 people. The company is managed by 23 executives with a total tenure of roughly 75 years, averaging almost 3.0 years of service per executive, having 1.39 employees per reported executive. Analysis of I Mab's management performance can provide insight into the company performance.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

I Mab Management Team Effectiveness

The company has return on total asset (ROA) of (0.1036) % which means that it has lost $0.1036 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1846) %, meaning that it created substantial loss on money invested by shareholders. I Mab's management efficiency ratios could be used to measure how well I Mab manages its routine affairs as well as how well it operates its assets and liabilities.
I Mab has a total of 115.27 Million outstanding shares. I Mab secures tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as I Mab in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of I Mab, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

I Mab Workforce Comparison

I Mab is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 914. I Mab holds roughly 32.0 in number of employees claiming about 4% of equities under Health Care industry.

I Mab Notable Stakeholders

An I Mab stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as I Mab often face trade-offs trying to please all of them. I Mab's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting I Mab's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
XiYong MBADirector CEOProfile
Raj KannanCEO DirectorProfile
Wei FuExecutive ChairmanProfile
CLP EsqCOO CFOProfile
Sean MBAChief DirectorProfile
Louie MDInterim OfficerProfile
Richard MBACOO CFOProfile
Weiming TangExecutive OfficerProfile
Jerry WangCoFounder OfficerProfile
Cheng LiChief OfficerProfile
Skelton JosephChief OfficerProfile
John MDChief OfficerProfile
Kyler LeiChief OfficerProfile
Tianyi ZhangVice RelationsProfile
Claire MDSenior DevelopmentProfile
Jingwu MDFounder ChairmanProfile
Ivan ZhuChief OfficerProfile
Min YinSenior OperationsProfile
Phillip MDChief OfficerProfile
Gigi FengChief OfficerProfile
Fernando SallesSenior DevelopmentProfile
Claire XuHead siteProfile
Tyler EhlerSenior RelationsProfile
String symbol = request.getParameter("s");

About I Mab Management Performance

The success or failure of an entity such as I Mab often depends on how effective the management is. I Mab management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IMAB management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IMAB management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 378 people.
Please note, the presentation of I Mab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, I Mab's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of I Mab's management manipulating its earnings.

I Mab Workforce Analysis

Traditionally, organizations such as I Mab use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare I Mab within its industry.

I Mab Manpower Efficiency

Return on I Mab Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.6M
Net Loss Per Executive2.2M
Working Capital Per Employee5.3M
Working Capital Per Executive7.3M
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Consideration for investing in IMAB Stock

If you are still planning to invest in I Mab check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the I Mab's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance